Official NIH NLM MEDLINE / PubMed Citation • PMID: 42970292
Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer
JAMA network open
Verbatim Formal Study Abstract
Of 304 participants randomized, 214 had complete data. The mean (SD) age was 58.9 (10.8) years. Mean (SD) total costs were highest for the EUC arm ($11 596.10 [$30 231.95]) compared with the app arm ($6682.15 [$12 963.34]; difference, -$4913.95 [95% CI, -$12 864.27 to $3036.37]) and app plus feedback arm ($11 407.85 [$47 068.42]; differen.